|
Cost-effective prevention of HIV-related Opportunistic Infections |
|
|
|
Cotrimoxazole prophylaxis, which prevents deaths and hospital admissions across all ages of individuals with HIV infection in resource-limited countries, is cheap. Economic research in adults in Uganda, and more recently in children in Zambia, has shown that Cotrimoxazole is highly costeffective. Specific research in Zambia has even found that it could be cost saving: if all HIV-infected children in Zambia received Cotrimoxazole prophylaxis, the net effect could be savings to the health system in the range of US$2.9 - 9.6 million per year.
|
|
Read more...
|
|
|
Job Vacancy for Health Systems Research Fellow |
|
|
|
We have an exciting vacancy for a Research Fellow to work as part of the Evidence for Action research consortium. This post will mainly focus on developing work under theme three of the consortium’s workplan, examining the level of integration of ART programmes with country health systems.
|
|
Read more...
|
|
|
About Evidence for Action |
|
|
|
|
Effective prevention, treatment and care services are essential to reduce the appalling waste of human life due to HIV, which has killed over 25 million people since the start of the epidemic, with 2.8m dying in 2005 alone. Evidence for Action is a five-year international research programme with core funding from the UK Department for International Development. The Evidence for Action consortium focuses on HIV treatment and care systems. The goal of the research programme is to contribute to knowledge on how to design, manage and deliver comprehensive HIV treatment and care programmes in resource poor settings. The partners to this consortium are leaders in research into HIV care for children and adults, and systems of delivery. They also include experts in policy and advocacy work, and civil society strengthening. Bringing these institutions together will deliver research solutions that can be translated into policy and actions rapidly and on a large scale in developing countries. |
|
Read more...
|
|
|
